Clinical Trial Update: Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating decitabine with total-body irradiation followed by donor bone marrow transplant and cyclophosphamide for relapsed or refractory acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Decitabine (Decitabine)
• Total Body Irradiation

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission | Phase 2 | Status: COMPLETED | Results posted: 2019-05-22